CHF248.50
0.64% yesterday
SIX Swiss Exchange, Jul 02, 05:30 pm CET
ISIN
CH0012032048
Symbol
ROG
Index
Sector
Industry

Roche Share price

CHF248.50
+16.40 7.07% 1M
+4.00 1.64% 6M
+4.00 1.64% YTD
-24.95 9.12% 1Y
-101.05 28.91% 3Y
-30.75 11.01% 5Y
-15.00 5.69% 10Y
SIX Swiss Exchange, Closing price Tue, Jul 02 2024
-1.60 0.64%
ISIN
CH0012032048
Symbol
ROG
Index
Sector
Industry

Key metrics

Market capitalization CHF198.11b
Enterprise Value CHF222.33b
PER (TTM) P/E ratio 17.25
EV/FCF (TTM) EV/FCF 18.92
EV/Sales (TTM) EV/Sales 3.79
P/S ratio (TTM) P/S ratio 3.37
P/B ratio (TTM) P/B ratio 6.76
Dividend yield 3.86%
Last dividend (FY23) CHF9.60
Sales growth (TTM) Sales growth -7.21%
Turnover (TTM) Turnover CHF58.72b
EBIT (operating result TTM) EBIT CHF16.35b
Free cash flow (TTM) Free cash flow CHF11.75b
EPS (TTM) EPS CHF14.40
P/E ratio expected 15.02
P/S ratio expected 3.25
EV/Sales expected 3.65
Show more

Register now for free to activate an alarm for the Roche share.

Activate alerts on the share price, dividend yield, valuation (e.g. P/E ratio or EV/sales) or strategy scores and sit back and relax.

Roche Share analysis

Analyst opinions

23 Analysts have issued a Roche forecast:

8x Buy
35%
11x Hold
48%
4x Sell
17%

Analyst opinions

23 Analysts have issued a Roche forecast:

Buy
35%
Hold
48%
Sell
17%

Financial data from Roche

Dec '23
+/-
%
Net profit 11,498 11,498
7% 7%
20%
Depreciation and amortization 3,474 3,474
9% 9%
6%
Share compensation - -
-
-
Operating cash flow 15,493 15,493
13% 13%
26%
Investments 4,649 4,649
2% 2%
8%
Dividend paid 7,590 7,590
2% 2%
13%
Free cash flow 11,751 11,751
19% 19%
20%

Figures in millions CHF.

Don't miss a thing! We will send you all news about the Roche share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Roche Share News

Neutral
GlobeNewsWire
5 days ago
Basel, 28 June 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the extension of the Vabysmo® (faricimab) marketing authorisation to include the treatment of visual impairment due to macular edema secondary to retinal vein occlusion (RVO). A final decision regar...
Neutral
GlobeNewsWire
5 days ago
Basel, 28 June 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for PiaSky® (crovalimab) for the treatment of paroxysmal nocturnal haemoglobinuria (PNH). The CHMP has recommended PiaSky, a novel recycling monoclonal antibody that inhibits the complement protei...
Neutral
GlobeNewsWire
6 days ago
Basel, 27 June 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the World Health Organization (WHO) has awarded the cobas® HPV test prequalification designations for use on the cobas® 5800 system and for self-collected samples on the cobas® 5800, 6800 and 8800 systems. These new prequalification designations come just one month after the U.S. Food and Drug Administration approved ...
More Roche News

Company profile

Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Head office Switzerland
CEO Thomas Schinecker
Employees 103,605
Founded 1896
Website www.roche.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today